glp 1 agonist crohn's disease Frontiers Pharmacological interventions for obesity in
Description
2024 Sep;63(9):1128-1130
Patients regained weight by half roughly every 23 weeks, with broadly similar modeled trajectories across different GLP-1RAs
GLP-1RA Linked to Higher Atrial Fibrillation Risk in Diabetic Patients A new study by CoDES faculty Dr
Initially approved for T2D management, GLP-1 RAs have also demonstrated cardiovascular and renal benefits [5,6,7]
